BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive LeukemiaMatthew S. Zabriskie, Thomas O’Hare, Johanna Estrada et al.|Cancer Cell|2014Cited by 366
Multiple pathways guide oxygen diffusion into flavoenzyme active sitesRiccardo Baron, J. Andrew McCammon, Conor T. Riley et al.|Proceedings of the National Academy of Sciences|2009Cited by 173